Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
单位：[1]China-Japan Union Hospital of Jilin University, Changchun, China吉林大学中日联谊医院[2]Peking University People’s Hospital, Beijing, China[3]The First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, China[4]Shanghai Changzheng Hospital, Shanghai, China[5]Sun Yat-sen University – The Third Affiliated Hospital, Guangzhou, China中山大学附属第三医院[6]China-Japan Friendship Hospital, Beijing, China[7]The First Affiliated Hospital of Harbin Medical University, Harbin, China[8]West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[9]UCB Pharma, Monheim, Germany[10]UCB Pharma, Tokyo, Japan[11]UCB Pharma, Slough, United Kingdom[12]Peking University People's Hospital, Beijing, China
第一作者单位：[1]China-Japan Union Hospital of Jilin University, Changchun, China
共同第一作者：
推荐引用方式(GB/T 7714)：
Bi Liqi,Li Yuhui,He Lan,et al.Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study[J].ARTHRITIS & RHEUMATOLOGY.2017,69:
APA：
Bi, Liqi,Li, Yuhui,He, Lan,Xu, Huji,Gu, Jieruo...&Li, Zhanguo.(2017).Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.ARTHRITIS & RHEUMATOLOGY,69,
MLA：
Bi, Liqi,et al."Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study".ARTHRITIS & RHEUMATOLOGY 69.(2017)
医学